Mirion Technologies Inc (MIR)
11.04
-0.14
(-1.30%)
USD |
NYSE |
Apr 24, 16:00
11.04
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.495B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 32.46% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.705 |
| Price to Book Value | 1.680 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.462 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 62.20% |
Profile
| Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment. |
| URL | https://www.mirion.com |
| Investor Relations URL | https://ir.mirion.com/ |
| HQ State/Province | Georgia |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Apr. 30, 2024 |
| Last Earnings Release | Feb. 13, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment. |
| URL | https://www.mirion.com |
| Investor Relations URL | https://ir.mirion.com/ |
| HQ State/Province | Georgia |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Apr. 30, 2024 |
| Last Earnings Release | Feb. 13, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |